08:30 - 09:00 Opening

09:00 - 10:30 Session 1: Use of molecular technologies for diagnosis and monitoring of hematological malignancies: an overview of accessible technologies vs NGS panels

• Lecture
• Clinical Case
• Self-assessment Case
• Panel discussion

10:30 - 11:00 Coffee break

11:00 - 12:30 Session 2: Novel agents and autologous transplant in the management of treatment resistant T & B cell Lymphomas

• Lecture
• Clinical Case
• Self-assessment Case
• Panel discussion

12:30 - 14:00 Lunch & prayers

14:00 - 15:30 Session 3: Updated management of Hodgkin Lymphoma

• Lecture
• Clinical Case
• Self-assessment Case
• Panel discussion

15:30 - 15:45 Coffee break

15:45 - 17:15 Session 4: Management of treatment resistant or relapsed acute myeloid leukemia

• Lecture
• Clinical Case
• Self-assessment Case
• Panel discussion

09:00 - 10:30 Session 5: Current management of relapsed Acute Lymphoblastic leukemia

• Lecture
• Clinical Case
• Self-assessment Case
• Panel discussion

10:30 - 11:00 Coffee break

11:00 - 12:30 Session 6: Updates in the management of thalassemia

• Lecture
• Clinical Case
• Self-assessment Case
• Panel discussion

12:30 - 14:00 Lunch & prayers

14:00 - 15:30 Session 7: Modern therapy for Multiple Myeloma and Chronic Lymphocytic Leukemia

• Lecture
  Roberto Mina (Italy)
• Clinical Case
• Self-assessment Case
  Roberto Mina (Italy)
• Panel discussion

15:30 - 15:45 Coffee break

15:45 - 17:15 Session 8: Updates on cellular therapy: Application of ASCT and CART cell therapy

• Lecture
  Shahram Kordasti (United Kingdom)
• Clinical Case
• Self-assessment Case
  Shahram Kordasti (United Kingdom)
• Panel discussion

17:15 - 17:30 Closing